Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells

Journal of Drug Targeting

Volumn 7, Issue 4, 1999, Pages 293-303

  Wightman, Lionel ^a   Patzelt, Erik ^a   Wagner, Ernst ^a   Kircheis, Ralf ^a  

^a BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

AVET; Interleukin 2; Melanoma; Polyethylenimine; Transfection; Transferrin

Indexed keywords

CELL SURFACE MARKER; CELL SURFACE PROTEIN; DNA; INTERLEUKIN 2; LUCIFERASE; POLYCATION; POLYETHYLENEIMINE; TRANSFERRIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA PROTEIN COMPLEX; DNA TRANSFECTION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; TUMOR CELL CULTURE;

EID: 0033391065     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869909085512     Document Type: Article

References (39)

1. Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J.P. and Demeneix, B.A. (1996) A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther., 7: 1947-1954.
2. Behr, J.P. (1994) Gene transfer with synthetic cationic amphiphiles: Prospects for gene therapy (Review). Bioconj. Chem., 5: 382-389.
3. Belli, F., Arienti, F., Sule-Suso, J., Clemente, C., Mascheroni, L., Cattelan, A., Sanatonio, C., Gallino, G.F., Melani, C., Rao, S., Colombo, M.P., Maio, M., Cascinelli, N. and Parmiani, G. (1997) Active immunisation of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: Evaluation of efficacy and tolerability. Cancer Immunol. Immunother., 44: 197-203.
4. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.P. (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in viro - polyethylenimine. Proc. Natl. Acad. Sci. USA, 92(16): 7297-7301.
5. Cotten, M., Saltik, M., Kursa, M., Wagner, E., Maass, G. and Birnstiel, M.L. (1994a) Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid. Virology, 205, 254-261.
6. Cotten, M., Baker, A., Saltik, M., Wagner, E. and Buschle, M. (1994b) Lipopolysaccharide is a frequent contaminant in plasmid preparations and can be toxic to primary cells in the presence of adenovirus. Gene Ther., 1: 239-246.
7. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. and Mulligan, R.C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA, 90: 3539-3543.
8. Erbacher, P., Remy, J.-S. and Behr, J.-P. (1999) Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther., 6: 138-145.
9. Fearon, E.R., Pardoll, D.M., Itaya, T., Golumbek, P., Levitsky, H., Simons, J.W., Karasuyama, H., Vogelstein, B. and Frost, P. (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60: 397-403.
10. Felgner. J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Feigner, P.L. (1994) Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem., 269: 2550-2561.
11. Golumbek, P.T., Azhari, R., Jaffee, E.M., Levitsky, H.I., Lazenby, A., Leong, K. and Pardoll, D.M. (1993) Controlled release, biodegradable cytokine depots: A new approach in cancer vaccine design. Cancer Res., 53: 5841-5844.
12. Goula, D., Remy, J.S., Erbacher, P., Wasowicz, M., Levi, G., Abdallah, B. and Demeneix, B.A. (1998a) Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther., 5: 712-717.
13. Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G. and Demeneix, B.A. (1998b) Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther., 5: 1291-1295.
14. Herlyn, M. and Koprowski, H. (1988) Melanoma antigens: Immunological and biological characterisation and clinical significance. Ann. Rev. Immunol., 6: 283-308.
15. Kircheis, R., Kichler, A., Wallner, G., Kursa, M., Ogris, M., Felzmann, T., Buchberger, M. and Wagner, E. (1997) Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther., 4: 409-418.
16. Kircheis, R., Küpcü, Z., Wallner, G. and Wagner, E. (1998) Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFNγ, or combination IL-2 + IFNγ. Cytokines. Cell. Mol. Ther., 4: 95-103.
17. Kircheis, R., Schüller, S., Brunner, S., Ogris, M., Heider, K.-H., Zauner, W. and Wagner, E. (1999) Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med., 1: 111-120.
18. Koppenhagen, F.J., Küpcü, Z., Wallner, G., Crommelin, D.J.A., Wagner, E., Storm, G. and Kircheis, R. (1998) Sustained cytokine release for anticancer vaccination: Liposomes as alternative for gene-modified tumor cells. Clin. Cancer Res., 4: 1881-1886.
19. Macfarlane, M.P., Yang, J.C., Guleria, A.S., White, R.L., Seipp, C.A., Einhorn, J.H., White, D.E. and Rosenberg, S.A. (1995) The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma. Cancer, 75: 1030-1037.
20. Nabel, G.J., Nabel, E.G., Yang, Z.Y., Fox, B.A., Plautz, G.E., Gao, X., Huang, L., Shu, S., Gordon, D. and Chang, A.E. (1993) Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA, 90: 11 307-11 311.
21. Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R. and Wagner, E. (1998) The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther., 5: 1425-1433.
22. Ogris, M., Brunner, S., Schüller, S., Kircheis, R. and Wagner, E. (1999) PEGylated DNA/Transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther., 6: 595-605.
23. Plank, C., Zatloukal, K., Cotten, M., Mechtler, K. and Wagner, E. (1992) Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem., 3: 533-539.
24. Plank, C., Oberhauser, B., Mechtler, K., Koch, C. and Wagner, E. (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem., 269: 12 918-12 924.
25. Plank, C., Mechtler, K., Szoka, F. and Wagner, E. (1996) Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum. Gene Ther., 7: 1437-1446.
26. Plautz, G.E., Yang, Z.-Y., Wu, B.-Y., Gao, X., Huang, L. and Nabel, G.J. (1993) Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA, 90: 4645-4649.
27. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwartzentruber, D.J., Weber, J.S., Parkinson, D.R., Seipp, C.A., Einhorn, J.H. and White, D.E. (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using hiuh-dose bolus interleukin 2. JAMA, 271: 907-913.
28. Schmidt, W., Schweighoffer, T., Herbst, E., Maass, G., Berger, M., Schilcher, F., Schaffner, G. and Birnstiel, M.L. (1995) Cancer vaccines: The interleukin-2 dosage effect. Proc. Natl. Acad. Sci. USA, 92: 4711-4714.
29. Schreiber, S., Kämpgen, E., Wagner, E., Pirkhammer, D., Trcka, J., Korschan, H., Lindemann, A., Dorffner, R., Kittler, H., Kasteliz, F., Küpcü, Z., Sinski, A., Zatloukal, K., Buschle, M., Schmidt, W., Birnstiel, M.L., Kempe, R.E., Voigt, T., Weber, H., Pehamberger, H., Mertelsmann, R., Bröcker, E.B., Wolff, K. and Stingl, G. (1999) Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: Outcome of a Phase I Study. Hum. Gene Ther. 10: 983-993.
30. Sencer, S.F., Rich, M.L., Katsanis, E., Ochoa, A.C. and Anderson, P.M. (1991) Anti-tumor vaccine adjuvant effects of IL-2 liposomes in mice immunized against MCA-102 sarcoma. Eur. Cytokine Netw., 2:311-318.
31. Simons, J.W., Jaffee, E.M., Weber, C.E., Levitsky, H.I., Nelson, W.G., Carducci, M.A., Lazenby, A.J., Cohen, L.K., Finn, C.C., Clift, S.M., Hauda, K.M., Beck, L.A., Leiferman, K.M., Owens Jr., A.H., Piantadosi, S., Dranoff, G., Mulligan, R.C., Pardoll, D.M. and Marshall, F.F. (1997) Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo Granulocyte-Macrophage Colony-Stimulating Factor gene transfer. Cancer Res., 57: 1537-1546.
32. Soiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J.C., Hodi, F.C., Liebster, L., Lam, P., Mentzer, S., Singer, S., Tanabe, K.K., Cosimi, A.B., Duda, R., Sober, A., Bhan, A., Daley, J., Neuberg, D., Parry, G., Rokovich, J., Richards, L., Drayer, J., Berns, A., Clift, S., Cohen, L.S., Mulligan, M.C. and Dranoff, G. (1998) Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA, 95: 13 141-13 146.
33. Tang, M.X., Redemann, C.T. and Szoka Jr., F.C. (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconj. Chem., 7: 703-714.
34. Van Slooten, M.L., Kircheis, R., Koppenhagen, F.J., Wagner, E. and Storm, G. (1999) Liposomes as cytokine-supplement in tumor cell-based vaccines. Int. J. Pharmaceutics, 183: 33-36.
35. Vile, R. and Hart, I. (1993) In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res., 53: 962-967.
36. Wagner, E., Gotten, M., Mechtler, K., Kirlappos, H. and Birnstiel, M.L. (1991) DNA-binding transferrin conjugates as functional gene-delivery agents: Synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconj. Chem., 2: 226-231.
37. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D.T. and Birnstiel, M.L. (1992) Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA, 89: 6099-6103.
38. Zatloukal, K., Schneeberger, A., Berger, M., Schmidt, W., Koszik, F., Kutil, R., Cotten, M., Wagner, E., Buschle, M., Maass, G., Payer, E., Stingl, G. and Birnstiel, M.L. (1995) Elicitation of a systemic and protective anti-melanoma immune response by an IL-2 based vaccine. J. Immunol., 154: 3406-3419.
39. Zauner, W., Blaas, D., Küchler, E. and Wagner, E. (1995) Rhinovirus mediated endosomal release of transfection complexes. J. Virol., 69: 1085-1092.